{
    "Trade/Device Name(s)": [
        "Simplexa HSV 1 & 2 Direct",
        "Simplexa HSV 1 & 2 Positive Control Pack"
    ],
    "Submitter Information": "Focus Diagnostics, Inc.",
    "510(k) Number": "K150962",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142738"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQO"
    ],
    "Summary Letter Date": "August 25, 2015",
    "Summary Letter Received Date": "August 26, 2015",
    "Submission Date": "August 20, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Herpes Simplex Virus 1 DNA",
        "Herpes Simplex Virus 2 DNA"
    ],
    "Specimen Type(s)": [
        "Genital lesion swabs"
    ],
    "Specimen Container(s)": [
        "Swab in transport media (BD VTM, M4, M4RT, M5, M6, UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "3M Integrated Cycler"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Multiplex PCR"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Differentiation of HSV-1/HSV-2 DNA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "System",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Simplexa HSV 1 & 2 Direct qualitative real-time PCR assay system to detect and differentiate HSV-1 and HSV-2 DNA in genital lesion swab specimens",
    "Indications for Use Summary": "For qualitative detection and differentiation of HSV-1 and HSV-2 DNA in genital lesion swabs from patients with signs and symptoms of genital HSV infection; aids differential diagnosis of HSV-1 and HSV-2 genital infections and used with 3M Integrated Cycler; not intended for blood or blood products.",
    "fda_folder": "Microbiology"
}